Yorvipath (palopegteriparatide)

• Multiple daily injections of palopegteriparatide may lead to unintended fluctuations in serum calcium levels. Close monitoring of calcium levels is essential to avoid complications related to both hypercalcemia and hypocalcemia during therapy.
  
• Patients using Yorvipath injection are at risk of developing serious hypercalcemia. Regular monitoring of serum calcium is necessary, especially in those with predisposing conditions. Physicians should adjust dosages accordingly to mitigate the risk of elevated calcium levels.
  
• This medicinal product can also cause serious hypocalcemia, particularly in patients with underlying deficiencies or conditions affecting calcium metabolism. Routine checks of serum calcium are crucial to prevent severe symptoms related to low calcium levels during treatment.
  
• There is a potential risk of osteosarcoma associated with prolonged use of Yorvipath injection. Patients should only use this medication for the duration prescribed by healthcare professionals, and any signs of bone-related issues must be reported immediately.
  
• Orthostatic hypotension has been reported in patients receiving treatment with this medicine. Individuals may experience dizziness or fainting, particularly when rising from a sitting or lying position. Monitoring blood pressure regularly and avoiding sudden postural changes can help mitigate this risk.
  
• The safety of palopegteriparatide during pregnancy has not been fully established. Pregnant women should use this medication only if the potential benefits outweigh the risks, and it should be avoided unless absolutely necessary during pregnancy.
  
• It is unclear if this therapeutic drug passes into breast milk. Therefore, breastfeeding mothers should exercise caution when using this medication and consult their healthcare provider (HCP) to weigh the benefits and potential risks before continuing treatment while nursing.
  

What documents are required to import YORVIPATH to India?

YORVIPATH (palopegteriparatide) injection can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
  
• Patients diagnostic reports
  
• Patient ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
  
• Import permit if applicable

Is YORVIPATH available in India?

YORVIPATH (palopegteriparatide injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Yorvipath in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
  
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
  
• Medicine Price.
  
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
  
• Ensuring 100% transparency.

YORVIPATH can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of YORVIPATH (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Yorvipath injection price in India. 

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source the YORVIPATH (Cancer Treatment Medicines) from across the globe and can supply it. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Yorvipath®?

Palopegteriparatide is a Generic Name for the trade name drug Yorvipath®.

What is the Manufacturer’s Name of Yorvipath®?

Yorvipath® is manufactured by Ascendis Pharma, Inc.

Is Yorvipath® approved by the FDA?

Yes, Yorvipath® is approved by the FDA. Date of first approval: August 09, 2024.

What is the dosage and form of Yorvipath® supplied?

Yorvipath® is supplied as an injection in a single-patient-use prefilled pen for subcutaneous use, available in the following dosages: 168 mcg/0.56 mL, 294 mcg/0.98 mL, and 420 mcg/1.4 mL.

What are the most common side effects of Yorvipath®? 

The most common side effects of Yorvipath® are back pain, injection site reactions, vasodilatory signs and symptoms, headache, diarrhea, oropharyngeal pain, and hypercalcemia.

How much does Yorvipath® Prefilled Pens cost in India?

Prices may fluctuate over time due to market dynamics and regulatory changes. To obtain accurate and up-to-date information on Yorvipath injection cost in India, it is recommended that you Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Yorvipath® Prefilled Pens be available in SAARC countries? 

Apart from Gulf countries, Yorvipath® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the supply of Yorvipath® injections in these countries, ensuring access to this therapeutic drug through legal and reliable channels.

Is it safe to buy Yorvipath® Prefilled Pens online in India?

Yes, one can buy Yorvipath injections online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Yorvipath® injections through legal channels. 

What are the storage conditions of Yorvipath® Prefilled Pens?

Store prefilled pens in their original packaging, away from heat and protected from light. Before the first use, keep the medicine refrigerated at a temperature of 2°C to 8°C (36°F to 46°F). Do not freeze.